再生医療の世界市場:細胞治療、遺伝子治療、免疫治療、組織工学

◆英語タイトル:Regenerative Medicines Market by Therapy (Cell Therapy, Gene Therapy, Immunotherapy, Tissue Engineering), Product (Cell-Based, Acellular), Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System), Region - Global Forecast to 2021
◆商品コード:MAM-BT-4419
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年7月7日
◆ページ数:160
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、再生医療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、治療分野別分析、製品別分析、用途別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global regenerative medicines market size is expected to reach USD 49.41 Billion by 2021, at a CAGR of 23.7% during the forecast period of 2016 to 2021.
The report on global market analyzes and segments the market on the basis of product, therapy, application, and region. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global regenerative medicines market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

Regenerative medicines replace or regenerate human cells, tissues, or organs, to restore normal function. These medicines repair tissue or organ function lost due to old age, disease, congenital defects, or damage due to trauma, by stimulating previously irreparable organs.

The driving forces for the global market include increasing use of regenerative medicines in cancer research and drug discovery, increasing investments by pharmaceutical companies, government initiatives, and rapid increase in the organ transplantation. The restraints for this market include lack of experienced professionals and budget constraints.

By product, cell-based products segment dominated the regenerative medicines market in 2015 due to large number of organ transplantation surgeries and extensive applications of cell-based products in the treatment of many diseases. Cell-based products are further segmented into allogeneic and autologous-based products.

By therapy, the segments are cell therapy, gene therapy, immunotherapy, and tissue engineering. The cell therapy segment is expected to dominate the market in 2016 owing to the availability of various cell therapy products and investments from the pharmaceutical companies.

By application, the segments are orthopedic & musculoskeletal spine, dermatology, CNS, cardiovascular, oncology, diabetes, and others where orthopedic & musculoskeletal spine segment is estimated to dominate the market in 2016 owing to increasing investments in orthopedic research and increasing number of musculoskeletal cases. According to the U.S. Centers for Medicare and Medicaid Services, approximately 900,000 surgeries requiring bone restructuring or regeneration are performed annually, with the most common being spinal fusion (about 450,000 surgeries performed annually in the U.S.).

The global market was dominated by North America in 2015, followed by Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to continue to lead the market in coming years, followed by Europe. The market in Asia-Pacific is expected to have the highest CAGR during the forecast period from 2016 to 2021. The growth in this region is expected to be driven by of the increasing research in regenerative medicines especially in Japan, increasing per capita healthcare expenditure, and increasing government initiatives.

Some of the key players in the global regenerative medicines market are Celgene Corporation (U.S.), Acelity (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), among others.

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency & Pricing
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 28)
4.1 Lucrative Opportunities in the Regenerative Medicines Market

5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market Segmentation, By Therapy
5.2.2 Market Segmentation, By Product
5.2.3 Market Segmentation, By Application
5.3 Market Dynamics
5.4 Drivers
5.4.1 Government and Private Funding to Support the Development of Regenerative Medicines Products
5.4.2 Increase in Global Healthcare Expenditure
5.4.3 Increase in Aging Population
5.5 Restraints
5.5.1 Stringent Regulatory Approval Process for Regenerative Medicines
5.5.2 Ethical Issues With the Use of Embryonic Stem Cell for Research and Development
5.6 Opportunities
5.6.1 Rising Demand for Organ Transplantation
5.6.2 Strong Product Pipeline to Drive the Market
5.6.3 Increase in R&D Spending
5.7 Challenges
5.7.1 Lack of Clear Regulatory Guidelines
5.7.2 High Costs Incurred in Stem Cell Processing

6 Global Regenerative Medicines Market, By Product (Page No. – 40)
6.1 Introduction
6.2 Cell-Based Products
6.2.1 Autologous Cell-Based Products
6.2.2 Allogeneic Cell-Based Products
6.3 Acellular Products

7 Global Regenerative Medicines Market, By Therapy (Page No. – 50)
7.1 Introduction
7.2 Cell Therapy
7.3 Gene Therapy
7.4 Tissue Engineering
7.5 Immunotherapy

8 Regenerative Medicines Market, By Application (Page No. – 58)
8.1 Introduction
8.2 Orthopedic & Musculoskeletal Spine
8.3 Dermatology
8.4 Cardiovascular
8.5 Central Nervous System
8.6 Oncology
8.7 Diabetes
8.8 Others

9 Global Regenerative Medicines Market, By Region (Page No. – 71)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 126)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 New Product Launches
10.3.2 Acquisitions
10.3.3 Regulatory Approvals
10.3.4 Partnerships

11 Company Profile (Page No. – 133)
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 Introduction
11.2 Vertex Pharmaceuticals Incorporated
11.3 Celgene Corporation
11.4 Acelity (KCI Licensing)
11.5 Nuvasive, Inc.
11.6 Organogenesis Inc.
11.7 Japan Tissue Engineering Co., Ltd (Subsidiary of Fujifilm Holdings Corporation)
11.8 Vericel Corporation
11.9 Cytori Therapeutics Inc.
11.10 Stemcells, Inc.
11.11 Advantagene, Inc.
11.12 Mesoblast Ltd

*Details Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 153)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Available Customizations
12.6 Related Reports

List of Tables (75 Tables)

Table 1 Global Regenerative Medicines Market Size, By Product, 2014–2021 (USD Billion)
Table 2 Cell-Based Market Size, By Type, 2014–2021 (USD Billion)
Table 3 Cell-Based Market Size, By Region, 2014–2021 (USD Billion)
Table 4 Autologous Market Size, By Region, 2014–2021 (USD Billion)
Table 5 Allogeneic Market Size, By Region, 2014–2021 (USD Billion)
Table 6 Acellular Market Size, By Region, 2014–2021 (USD Billion)
Table 7 Global Market, By Therapy, 2014–2021 (USD Billion)
Table 8 Cell Therapy Market, By Region, 2014-2021 (USD Billion)
Table 9 Gene Therapy Market, By Region, 2014-2021 (USD Billion)
Table 10 Tissue Engineering Market, By Region, 2014-2021 (USD Billion)
Table 11 Immunotherapy Market, By Region, 2014-2021 (USD Billion)
Table 12 Market Size, By Application, 2014–2021 (USD Billion)
Table 13 Orthopedic & Musculoskeletal Spine Market, By Region, 2014–2021 (USD Billion)
Table 14 Dermatology Market, By Region, 2014–2021 (USD Billion)
Table 15 Cardiovascular Market, By Region, 2014–2021 (USD Billion)
Table 16 Central Nervous System Market, By Region, 2014–2021 (USD Billion)
Table 17 Oncology Market, By Region, 2014–2021 (USD Billion)
Table 18 Diabetes Market, By Region, 2014–2021 (USD Billion)
Table 19 Others Market, By Region, 2014–2021 (USD Billion)
Table 20 Global Market, By Region, 2014–2021 (USD Billion)
Table 21 North America Market, By Geography, 2014–2021 (USD Billion)
Table 22 North America Market, By Product, 2014–2021 (USD Billion)
Table 23 North America Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 24 North America Market, By Application, 2014–2021 (USD Billion)
Table 25 North America Market, By Therapy, 2014–2021 (USD Billion)
Table 26 U.S. Market, By Product, 2014–2021 (USD Billion)
Table 27 U.S. Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 28 U.S. Market, By Application, 2014–2021 (USD Billion)
Table 29 U.S. Market, By Therapy, 2014–2021 (USD Billion)
Table 30 Canada Market, By Product, 2014–2021 (USD Billion)
Table 31 Canada Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 32 Canada Market, By Application, 2014–2021 (USD Billion)
Table 33 Canada Market, By Therapy, 2014–2021 (USD Billion)
Table 34 Europe Market, By Geography, 2014–2021 (USD Billion)
Table 35 Europe Market, By Product, 2014–2021 (USD Billion)
Table 36 Europe Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 37 Europe Market, By Application, 2014–2021 (USD Billion)
Table 38 Europe Market, By Therapy, 2014–2021 (USD Billion)
Table 39 Germany Market, By Product, 2014–2021 (USD Billion)
Table 40 Germany Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 41 Germany Market, By Application, 2014–2021 (USD Billion)
Table 42 Germany Market, By Therapy, 2014–2021 (USD Billion)
Table 43 UK Market, By Product, 2014–2021 (USD Billion)
Table 44 UK Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 45 UK Market, By Application, 2014–2021 (USD Billion)
Table 46 UK Market, By Therapy, 2014–2021 (USD Billion)
Table 47 France Market, By Product, 2014–2021 (USD Billion)
Table 48 France Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 49 France Market, By Application, 2014–2021 (USD Billion)
Table 50 France Market, By Therapy, 2014–2021 (USD Billion)
Table 51 Italy Market, By Product, 2014–2021 (USD Billion)
Table 52 Italy Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 53 Italy Market, By Application, 2014–2021 (USD Billion)
Table 54 Italy Market, By Therapy, 2014–2021 (USD Billion)
Table 55 Spain Market, By Product, 2014–2021 (USD Billion)
Table 56 Spain Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 57 Spain Market, By Application, 2014–2021 (USD Billion)
Table 58 Spain Market, By Therapy, 2014–2021 (USD Billion)
Table 59 Rest of Europe(RoE) Market, By Product, 2014–2021 (USD Billion)
Table 60 Rest of Europe(RoE) Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 61 Rest of Europe (RoE) Market, By Application, 2014–2021 (USD Billion)
Table 62 Rest of Europe (RoE) Market, By Therapy, 2014–2021 (USD Billion)
Table 63 Asia-Pacific Market, By Product, 2014–2021 (USD Billion)
Table 64 Asia-Pacific Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 65 Asia-Pacific Market, By Application, 2014–2021 (USD Billion)
Table 66 Asia-Pacific Market, By Therapy, 2013–2021 (USD Billion)
Table 67 RoW Market, By Product, 2014–2021 (USD Billion)
Table 68 RoW Cell-Based Products Market, By Type, 2014–2021 (USD Billion)
Table 69 RoW Market, By Application, 2014–2021 (USD Billion)
Table 70 RoW Market, By Therapy, 2014–2021 (USD Billion)
Table 71 New Product Launches, 2013–2016
Table 72 Acquisitions, 2014–2016
Table 73 Regulatory Approvals, 2013–2016
Table 74 Partnerships, 2016
Table 75 Agreements, 2013–2016

List of Figures (91 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Product (2016 vs 2021)
Figure 7 Market, By Therapy, 2016 vs 2021
Figure 8 Orthopedic & Musculoskeletal Spine Form the Largest Application Segment
Figure 9 Global Market to Witness High Growth During the Forecast Period
Figure 10 Cell Therapy Segment Dominates the Market
Figure 11 Asia to Witness the Highest Growth Rate During the Forecast Period
Figure 12 Market Segmentation
Figure 13 Market Segmentation, By Therapy
Figure 14 Market Segmentation, By Product
Figure 15 Market Segmentation, By Application
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Global Market, By Product
Figure 18 Cell-Based Products Segment Accounted for the Largest Share of the Global Market in 2015
Figure 19 Cell-Based Products, By Type
Figure 20 Allogeneic Segment Accounted for the Largest Share of the Cell-Based Regenerative Medicines Market in 2015
Figure 21 North America Estimated to Account for the Largest Share of the Cell-Based Regenerative Medicines Market in 2016
Figure 22 North America Estimated to Account for the Largest Share of the Autologous Regenerative Medicines Market in 2016
Figure 23 North America to Account for the Largest Share of Allogeneic Regenerative Medicines Market in 2016
Figure 24 Asia-Pacific Expected to Be the Fastest-Growing Segment of the Acellular Regenerative Medicines Market During the Forecast Period
Figure 25 Global Market, By Therapy
Figure 26 The Cell Therapy Segment to Lead the Global Market During the Forecast Period
Figure 27 Cell Therapy Market, By Region, 2016 & 2021 (USD Billion)
Figure 28 Gene Therapy Market, By Region, 2016 & 2021 (USD Billion)
Figure 29 Tissue Engineering Market, By Region, 2016 & 2021 (USD Billion)
Figure 30 Immunotherapy Market, By Region, 2016 & 2021 (USD Billion)
Figure 31 Market Segmentation, By Application
Figure 32 Orthopedic & Musculoskeletal Spine Segment Dominated the Regenerative Medicine Application Market in 2015
Figure 33 North America Accounted for the Largest Share of the Global Market for Orthopedic & Musculoskeletal Spine in 2015
Figure 34 North America Dominated the Market for Dermatology in 2015
Figure 35 Asia-Pacific is the Fastest Growing Region in the Global Market for Cardiovascular Applications
Figure 36 North America Dominated the Market for Central Nervous System Applications in 2015
Figure 37 Asia-Pacific is the Fastest Growing Region in the Global Market for Oncology Application
Figure 38 Asia-Pacific is the Fastest Growing Region in the Global Market for Diabetes Application
Figure 39 North America Dominated the Market for Other Applications in 2015
Figure 40 Regional Snapshot (2015)
Figure 41 The Market in the Asia-Pacific Region is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 42 North America Market Snapshot
Figure 43 Cell-Based Products Segment Accounted for the Largest Share of the North America Market in 2015
Figure 44 Orthopedic & Musculoskeletal Spine Application Segment Accounted for the Largest Share of the North America Regenerative Medicines Market in 2015
Figure 45 Cell Therapy Segment Accounted for the Largest Share of the North America Regenerative Medicines Therapy Market in 2015
Figure 46 Cell-Based Products Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Market in 2015
Figure 47 Orthopedic & Musculoskeletal Spine Application Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Market in 2015
Figure 48 Cell Therapy Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Therapy Market
Figure 49 Cell-Based Products Segment Accounted for the Largest Share of the Canada Regenerative Medicines Market in 2015
Figure 50 Orthopedic & Musculoskeletal Spine Application Segment Accounted for the Largest Share of the Canada Regenerative Medicines Market in 2015
Figure 51 Cell Therapy Segment Accounted for the Largest Share of the Canada Regenerative Medicines Therapy Market
Figure 52 Europe Regenerative Medicines Market Snapshot
Figure 53 Among Products, the Cell-Based Products Segment Led the Europe Regenerative Medicines Market in 2015
Figure 54 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the Europe Regenerative Medicines Market in 2015
Figure 55 The Cell Therapy Segment Led the Europe Regenerative Medicines Market in 2015
Figure 56 Cell-Based Products Segment Accounted for the Largest Share of the Germany Regenerative Medicines Market in 2015
Figure 57 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the Germany Regenerative Medicines Market in 2015
Figure 58 The Cell Therapy Segment Led the Germany Regenerative Medicines Market in 2015
Figure 59 Cell-Based Products Segment Accounted for the Largest Share of the U.K. Regenerative Medicines Market in 2015
Figure 60 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the UK Regenerative Medicines Market in 2015
Figure 61 The Cell Therapy Segment Led the UK Regenerative Medicines Market in 2015
Figure 62 Cell-Based Products Segment Accounted for the Largest Share of the France Regenerative Medicines Market in 2015
Figure 63 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the France Regenerative Medicines Market in 2015
Figure 64 The Cell Therapy Segment Led the France Regenerative Medicines Market in 2015
Figure 65 Cell-Based Products Segment Accounted for the Largest Share of the Italy Regenerative Medicines Market in 2015
Figure 66 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the Italy Regenerative Medicines Market in 2015
Figure 67 The Cell Therapy Segment Led the Italy Regenerative Medicines Market in 2015
Figure 68 Cell-Based Products Segment Accounted for the Largest Share of the Spain Regenerative Medicines Market in 2015
Figure 69 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the Spain Regenerative Medicines Market in 2015
Figure 70 The Cell Therapy Segment Led the Spain Regenerative Medicines Market in 2015
Figure 71 Cell-Based Products Segment Accounted for the Largest Share of the Rest of the Europe (RoE) Regenerative Medicines Market in 2015
Figure 72 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the Rest of Europe (RoE) Regenerative Medicines Market in 2015
Figure 73 The Cell Therapy Segment Led the Rest of Europe (RoE) Regenerative Medicines Market in 2015
Figure 74 Asia-Pacific Regenerative Medicines Market Snapshot
Figure 75 Among Products, the Cell-Based Products Segment Accounted for the Largest Share in the Asia-Pacific Regenerative Medicines Market in 2015
Figure 76 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the Asia-Pacific Regenerative Medicines Market in 2015
Figure 77 The Cell Therapy Segment Accounted for the Largest Share in the Asia-Pacific Regenerative Medicines in 2015
Figure 78 The Cell-Based Products Segment Accounted for the Largest Share in the RoW Regenerative Medicines Market in 2015
Figure 79 Among Applications, the Orthopedic & Musculoskeletal Spine Segment Accounted for the Largest Share in the RoW Regenerative Medicines Market in 2015
Figure 80 The Cell Therapy Segment Accounted for the Largest Share in the RoW Regenerative Medicines Market in 2015
Figure 81 Leading Market Players Adopted Both Organic and Inorganic Growth Strategies Over the Last Four Years (2013–2016)
Figure 82 Global Regenerative Medicines Market Share Analysis, By Key Player, 2015
Figure 83 Battle for Market Share: New Product Launches & Product Enhancements is the Key Strategy
Figure 84 Geographic Revenue Snapshot (2015)
Figure 85 Vertex Pharmaceuticals Incorporated: Company Snapshot
Figure 86 Celgene Corporation: Company Snapshot
Figure 87 Acelity (KCI Licensing): Company Snapshot
Figure 88 Nuvasive, Inc.: Company Snapshot
Figure 89 Vericel Corporation: Company Snapshot
Figure 90 Cytori Therapeutics Inc.: Company Snapshot
Figure 91 Stemcells, Inc.: Company Snapshot

【レポートのキーワード】

再生医療、細胞治療、遺伝子治療、免疫治療、組織工学、再生医学、細胞製品、医療、治療、応用

★調査レポート[再生医療の世界市場:細胞治療、遺伝子治療、免疫治療、組織工学]販売に関する免責事項
★調査レポート[再生医療の世界市場:細胞治療、遺伝子治療、免疫治療、組織工学]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆